Genet Med. 2010 Nov;12(11):742-5. doi: 10.1097/GIM.0b013e3181f8baad.
Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities.
Abstract
Laboratory evaluation of patients with developmental delay/intellectual disability, congenital anomalies, and dysmorphic features has changed significantly in the last several years with the introduction of microarray technologies. Using these techniques, a patient's genome can be examined for gains or losses of genetic material too small to be detected by standard G-banded chromosome studies. This increased resolution of microarray technology over conventional cytogenetic analysis allows for identification of chromosomal imbalances with greater precision, accuracy, and technical sensitivity. A variety of array-based platforms are now available for use in clinical practice, and utilization strategies are evolving. Thus, a review of the utility and limitations of these techniques and recommendations regarding present and future application in the clinical setting are presented in this study.
full-text ►
National Guideline Clearinghouse | Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities.
American College of Medical Genetics and Genomics
February 24, 2014
Guideline Title
Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities.
Bibliographic Source(s)
Manning M, Hudgins L, Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010 Nov;12(11):742-5. [38 references] PubMed  |
No hay comentarios:
Publicar un comentario